NCT06183281 Integrating Nonpharmacologic Strategies for Pain With Inclusion, Respect, and Equity
| NCT ID | NCT06183281 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, San Francisco |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 586 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 586 participants in total. It began in 2025-04-15 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
INSPIRE creates a trilingual mobile app and telehealth coaching program to promote non-pharmacologic strategies for pain management with Black, Chinese, and Latinx communities in the San Francisco Bay Area. Years 1-2 will develop the app and test it with a brief single arm pilot starting in Nov 2023. A full two arm randomized controlled trial (RCT) will being in early 2025 with changes in PEG scores as the primary outcome. Secondary outcomes include Helping to End Addiction Longterm (HEAL) common data elements.
Eligibility Criteria
Inclusion Criteria: 1. age 18 or older 2. speak English, Spanish, or Cantonese 3. have a UCSF Health or SFHN medical provider (any type) 4. be willing to use a smartphone (iOS or Android - either their own or one provided by the study) 5. have chronic, non-malignant pain for at least 3 months 6. be willing to participate in a 12 month patient-centered chronic pain management study where they will be randomized into one of two comparison arms Exclusion Criteria: * Severe mental illness or other condition preventing informed consent
Contact & Investigator
Jason Satterfield, PhD
PRINCIPAL INVESTIGATOR
University of California, San Francisco
Frequently Asked Questions
Who can join the NCT06183281 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06183281 currently recruiting?
Yes, NCT06183281 is actively recruiting participants. Contact the research team at Jason.Satterfield@ucsf.edu for enrollment information.
Where is the NCT06183281 trial being conducted?
This trial is being conducted at San Francisco, United States, San Francisco, United States.
Who is sponsoring the NCT06183281 clinical trial?
NCT06183281 is sponsored by University of California, San Francisco. The principal investigator is Jason Satterfield, PhD at University of California, San Francisco. The trial plans to enroll 586 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.